
Scribe’s cardiometabolic programs gain CIRM boost
BioWorld
|
June 19, 2026
X min read
BioWorld
|
June 19, 2026
Share on Social
More like this
Media
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
September 2, 2026
Read Now
Press
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
September 2, 2026
Read Now